123 related articles for article (PubMed ID: 11595281)
21. [Preparation and stability of recombinant human tumor necrosis factor-alpha-loaded stealth nanoparticles].
Fang C; Shi B; Pei YY
Yao Xue Xue Bao; 2004 Nov; 39(11):939-43. PubMed ID: 15696938
[TBL] [Abstract][Full Text] [Related]
22. Biodistribution and renal clearance of biocompatible lung targeted poly(ethylene glycol) (PEG) nanogel aggregates.
Deshmukh M; Kutscher HL; Gao D; Sunil VR; Malaviya R; Vayas K; Stein S; Laskin JD; Laskin DL; Sinko PJ
J Control Release; 2012 Nov; 164(1):65-73. PubMed ID: 23041417
[TBL] [Abstract][Full Text] [Related]
23. Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles.
Peracchia MT; Harnisch S; Pinto-Alphandary H; Gulik A; Dedieu JC; Desmaële D; d'Angelo J; Müller RH; Couvreur P
Biomaterials; 1999 Jul; 20(14):1269-75. PubMed ID: 10403044
[TBL] [Abstract][Full Text] [Related]
24. Stealth PEG-PHDCA niosomes: effects of chain length of PEG on niosomes in vitro complement consumption and phagocytic uptake.
Shi B; Fang C; You MX; Hong MH; Pei YY
Yao Xue Xue Bao; 2005 Nov; 40(11):976-81. PubMed ID: 16499079
[TBL] [Abstract][Full Text] [Related]
25. Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin.
Hong M; Zhu S; Jiang Y; Tang G; Pei Y
J Control Release; 2009 Jan; 133(2):96-102. PubMed ID: 18840485
[TBL] [Abstract][Full Text] [Related]
26. Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and Protein Lab-on-chip system.
Kim HR; Andrieux K; Delomenie C; Chacun H; Appel M; Desmaële D; Taran F; Georgin D; Couvreur P; Taverna M
Electrophoresis; 2007 Jul; 28(13):2252-61. PubMed ID: 17557357
[TBL] [Abstract][Full Text] [Related]
27. Enzymatic PEGylated Poly(lactone-co-β-amino ester) Nanoparticles as Biodegradable, Biocompatible and Stable Vectors for Gene Delivery.
Chen Y; Li Y; Gao J; Cao Z; Jiang Q; Liu J; Jiang Z
ACS Appl Mater Interfaces; 2016 Jan; 8(1):490-501. PubMed ID: 26673948
[TBL] [Abstract][Full Text] [Related]
28. Stealth PEGylated chitosan polyelectrolyte complex nanoparticles as drug delivery carrier.
Deng X; Zhao J; Liu K; Wu C; Liang F
J Biomater Sci Polym Ed; 2021 Aug; 32(11):1387-1405. PubMed ID: 33863271
[TBL] [Abstract][Full Text] [Related]
29. In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size.
Fang C; Shi B; Pei YY; Hong MH; Wu J; Chen HZ
Eur J Pharm Sci; 2006 Jan; 27(1):27-36. PubMed ID: 16150582
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive study of the drug delivery properties of poly(l-lactide)-poly(ethylene glycol) nanoparticles in rats and tumor-bearing mice.
Shalgunov V; Zaytseva-Zotova D; Zintchenko A; Levada T; Shilov Y; Andreyev D; Dzhumashev D; Metelkin E; Urusova A; Demin O; McDonnell K; Troiano G; Zale S; Safarovа E
J Control Release; 2017 Sep; 261():31-42. PubMed ID: 28611009
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain.
Parikh T; Bommana MM; Squillante E
Eur J Pharm Biopharm; 2010 Mar; 74(3):442-50. PubMed ID: 19941957
[TBL] [Abstract][Full Text] [Related]
32. Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery.
Lu W; Zhang Y; Tan YZ; Hu KL; Jiang XG; Fu SK
J Control Release; 2005 Oct; 107(3):428-48. PubMed ID: 16176844
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and characterization of amphiphilic block polymer poly(ethylene glycol)-poly(propylene carbonate)-poly(ethylene glycol) for drug delivery.
Li H; Niu Y
Mater Sci Eng C Mater Biol Appl; 2018 Aug; 89():160-165. PubMed ID: 29752085
[TBL] [Abstract][Full Text] [Related]
34. Biodistribution of colloidal gold nanoparticles after intravenous injection: Effects of PEGylation at the same particle size.
Takeuchi I; Onaka H; Makino K
Biomed Mater Eng; 2018; 29(2):205-215. PubMed ID: 29457594
[TBL] [Abstract][Full Text] [Related]
35. Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery.
Kaul G; Amiji M
Pharm Res; 2002 Jul; 19(7):1061-7. PubMed ID: 12180540
[TBL] [Abstract][Full Text] [Related]
36. Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles.
Peracchia MT; Vauthier C; Passirani C; Couvreur P; Labarre D
Life Sci; 1997; 61(7):749-61. PubMed ID: 9252249
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.
Yu H; Tang Z; Zhang D; Song W; Zhang Y; Yang Y; Ahmad Z; Chen X
J Control Release; 2015 May; 205():89-97. PubMed ID: 25529533
[TBL] [Abstract][Full Text] [Related]
38. Formulation and evaluation of paclitaxel-loaded polymeric nanoparticles composed of polyethylene glycol and polylactic acid block copolymer.
Araki T; Kono Y; Ogawara K; Watanabe T; Ono T; Kimura T; Higaki K
Biol Pharm Bull; 2012; 35(8):1306-13. PubMed ID: 22863930
[TBL] [Abstract][Full Text] [Related]
39. Effect of MePEG molecular weight and particle size on in vitro release of tumor necrosis factor-alpha-loaded nanoparticles.
Fang C; Shi B; Pei YY
Acta Pharmacol Sin; 2005 Feb; 26(2):242-9. PubMed ID: 15663906
[TBL] [Abstract][Full Text] [Related]
40. Selegiline-functionalized, PEGylated poly(alkyl cyanoacrylate) nanoparticles: Investigation of interaction with amyloid-β peptide and surface reorganization.
Le Droumaguet B; Souguir H; Brambilla D; Verpillot R; Nicolas J; Taverna M; Couvreur P; Andrieux K
Int J Pharm; 2011 Sep; 416(2):453-60. PubMed ID: 21251960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
